JPRN-UMIN000046354
Recruiting
未知
A retrospective study of cardiac event occurrence in thoracic carbon-ion radiotherapy - A retrospective study of cardiac event occurrence in thoracic carbon-ion radiotherapy
ational Institute for Quantum and Radiological Science and Technology0 sites200 target enrollmentDecember 13, 2021
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- ung cancer, liver cancer, esophageal cancer etc.
- Sponsor
- ational Institute for Quantum and Radiological Science and Technology
- Enrollment
- 200
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Cases in which the secondary use of clinical data is refused at the time of obtaining consent for treatment or other research, and cases in which the research subject or his/her representative refuses the use of clinical data for this research.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Prospective analysis of cardiovascular events based on titin concentration in patients with chronic heart failurechronic heart failureJPRN-UMIN000032341Kobe University Graduate School of Medicine Department of Internal Medicine Division of Cardiovascular Medicine70
Completed
Not Applicable
Beta-blockers and Airways DiseaseObstructive airways disease - COPDAsthmaRespiratory - Chronic obstructive pulmonary diseaseRespiratory - AsthmaACTRN12605000148673Belinda Cochrane50
Recruiting
Not Applicable
Investigating cardiovascular adverse events related to cancer treatment: a study of extreme toxicity using induced pluripotent stem cellscardiovascular adverse events after cancer treatment1008220610027655NL-OMON44465niversitair Medisch Centrum Groningen48
Active, not recruiting
Not Applicable
Estudio de eventos cardiovasculares para evaluar el potencial de aleglitazar en la reducción del riesgo cardiovascular en pacientes con un episodio reciente de síndrome coronario agudo (SCA) y diabetes mellitus tipo 2 (DM2).Cardiovascular outcomes study to evaluate the potential of aleglitazar to reduce cardiovascular risk in patients with a recent acute coronary syndrome (ACS) event and type 2 diabetes mellitus (T2D).Pacientes con diabetes tipo 2 con un episodio reciente de síndrome coronario agudo (SCA).Type 2 diabetes patients with a recent acute coronary syndrome (ACS) event.MedDRA version: 12.0Level: LLTClassification code 10007649Term: Cardiovascular disorderEUCTR2009-012269-71-ESF. Hoffmann-La Roche Ltd.6,000
Completed
Not Applicable
A prospective surveillance of cardiovascular events in antiplatelet-treated arteriosclerosis obliterans patients in Japan.Arteriosclerosis obliterans Peripheral arterial diseaseJPRN-UMIN000003385Mitsubishi Tanabe Pharma Corporation11,375